4-(3-Methylphenyl)Amino-3-Pyridinesulfonamide

We are 4-(3-Methylphenyl)Amino-3-Pyridinesulfonamide CAS:72811-73-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 4-(3-Methylphenyl)Amino-3-Pyridinesulfonamide
CAS.NO:   72811-73-5
Synonyms:
4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
4-(m-Tolylamino)pyridine-3-sulfonamide
4-[(3-Methylphenyl)amino]-3-pyridinesulfonamide
4-(3-methylanilino)pyridine-3-sulfonamide
3-Pyridinesulfonamide, 4-[(3-methylphenyl)amino]-

Molecular Formula: C12H13N3O2S
Molecular Weight: 263.31600

Physical and Chemical Properties:
Density: 1.357 g / cm3
Boiling point: 475.8ºC at 760 mmHg
Melting point: 162-164ºC
Flash point: 241.5ºC
Refractive index: 1.641

Specification:
Appearance:  White to off-white crystalline powder
Purity:≥99.0%
Loss on Drying:0.5 %Max
WATER(K.F):0.5%MAX
RESIDUE ON IGNITION:0.2%MAX
INDIVIDUAL IMPURITY:0.3%MAX
WATER(K.F):0.5%MAX

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
Intermediates of Torasemide CAS:56211-40-6.

4-(3-Methylphenyl)Amino-3-Pyridinesulfonamide


Related News: Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities.ethyl oleate We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.443305-33-7 At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities.(3-Fluoro-4'-butyl[1,1'-biphenyl]-4-yl)boronic acid Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.

Related Products
Product Name
3-Pyridylboronic acid View Details
2-(2,5-Diaminophenyl)ethanol sulfate View Details
D-tert-Leucine View Details
ethyl (2Z)-2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate manufacturer (3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane manufacturer 4-Fluorobenzoyl chloride manufacturer p-Bromofluorobenzene manufacturer 1-(4-bromophenyl)-3-(dimethylamino)-1-pyridin-3-ylpropan-1-ol manufacturer